Amicus Therapeutics (GB:0HF9)

Amicus (0HF9) Financial Statements


Amicus Financial Overview

Amicus's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Amicus is scheduled to report earnings on August 3, 2023, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 86.27M$ 88.10M$ 81.69M$ 80.73M$ 78.72M
Gross Profit$ 79.33M$ 78.71M$ 68.25M$ 72.53M$ 71.13M
EBIT$ -43.57M$ -60.96M$ -19.64M$ -52.99M$ -73.30M
EBITDA$ -44.83M$ -59.65M$ -18.36M$ -51.66M$ -71.89M
Net Income Common Stockholders$ 194.88M$ -55.87M$ -33.29M$ -62.16M$ -85.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 267.11M$ 293.60M$ 354.70M$ 386.84M$ 411.19M
Total Assets$ 700.52M$ 724.17M$ 759.53M$ 800.59M$ 826.94M
Total Debt$ 452.01M$ 452.12M$ 450.87M$ 451.04M$ 447.71M
Net Debt$ 184.90M$ 158.53M$ 96.17M$ 64.20M$ 36.51M
Total Liabilities$ 597.95M$ 601.12M$ 626.96M$ 627.16M$ 588.32M
Stockholders Equity$ 102.57M$ 123.05M$ 132.56M$ 173.43M$ 238.62M
Cash Flow-
Free Cash Flow$ -20.26M$ -80.04M$ -11.49M$ -16.22M$ -59.19M
Operating Cash Flow$ -18.32M$ -80.77M$ -11.63M$ -15.86M$ -58.31M
Investing Cash Flow$ 36.51M$ -66.70M$ 74.52M$ 26.29M$ 58.21M
Financing Cash Flow$ -7.83M$ 557.00K$ -559.00K$ 693.00K$ -8.15M
Currency in USD

Amicus Earnings and Revenue History

Amicus Debt to Assets

Amicus Cash Flow

Amicus Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis